Pathogenesis of Antiphospholipid Syndrome.
作者信息
Bo Ic Borut
机构信息
Department of Rheumatology, University Medical Centre, Vodnikova 62, S1-1000 Ljubljana, Slovenia.
出版信息
EJIFCC. 2004 Aug 31;15(3):54-57. eCollection 2004 Aug.
Abstract
摘要
相似文献
1
Pathogenesis of Antiphospholipid Syndrome.
EJIFCC. 2004 Aug 31;15(3):54-57. eCollection 2004 Aug.
2
[Antiphospholipid syndrome. Pathogenesis, molecular basis and clinical aspects].
Med Klin (Munich). 2001 Jun 15;96(6):331-42. doi: 10.1007/pl00002213.
3
Cofactor-Independent Antiphospholipid Antibodies: Implications for Pathogenesis, Diagnosis, and Treatment of Antiphospholipid Syndrome.
Hamostaseologie. 2019 Jun;39(2):188-194. doi: 10.1055/s-0038-1675355. Epub 2018 Nov 12.
4
Common infectious agents prevalence in antiphospholipid syndrome.
Lupus. 2009 Nov;18(13):1149-53. doi: 10.1177/0961203309345738.
5
6
Prolactin's role in the pathogenesis of the antiphospholipid syndrome.
Lupus. 2010 Nov;19(13):1515-9. doi: 10.1177/0961203310373781. Epub 2010 Jul 20.
7
Platelets and the antiphospholipid syndrome.
Lupus. 2008 Oct;17(10):888-94. doi: 10.1177/0961203308096344.
8
The antiphospholipid syndrome and infections in a child with trisomy 21.
Autoimmun Rev. 2008 Dec;8(2):121-3. doi: 10.1016/j.autrev.2008.05.004. Epub 2008 Jun 23.
9
Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
Acta Dermatovenerol Croat. 2016 Dec;24(4):305-306.
10
The catastrophic antiphospholipid syndrome in children.
Curr Opin Rheumatol. 2017 Sep;29(5):516-522. doi: 10.1097/BOR.0000000000000426.
引用本文的文献
1
Antiphospholipid Syndrome: A Comprehensive Clinical Review.
J Clin Med. 2025 Jan 23;14(3):733. doi: 10.3390/jcm14030733.
本文引用的文献
1
Concomitant isolation of protein C inhibitor and unnicked beta2-glycoprotein I.
Clin Chem Lab Med. 2004 Feb;42(2):171-4. doi: 10.1515/CCLM.2004.031.
2
THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS.
J Lab Clin Med. 1963 Sep;62:416-30.
3
High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome.
J Thromb Haemost. 2003 Apr;1(4):718-24. doi: 10.1046/j.1538-7836.2003.00102.x.
4
Antiphospholipid syndrome: pathogenic mechanisms.
Autoimmun Rev. 2003 Mar;2(2):86-93. doi: 10.1016/s1568-9972(02)00144-1.
5
10th International Congress on Antiphospholipid Antibodies--summary.
Autoimmun Rev. 2003 Mar;2(2):79-85. doi: 10.1016/s1568-9972(02)00142-8.
6
Anti-annexin V antibodies in patients with cerebrovascular disease.
Ann Rheum Dis. 2003 Feb;62(2):188-9. doi: 10.1136/ard.62.2.188.
7
Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions.
Arthritis Rheum. 2002 Dec;46(12):3283-9. doi: 10.1002/art.10634.
8
beta 2 Glycoprotein I--a key player in the antiphospholipid syndrome.
Isr Med Assoc J. 2002 Nov;4(11 Suppl):958-62.
9
Molecular pathogenesis of the antiphospholipid syndrome.
Circ Res. 2002 Jan 11;90(1):29-37. doi: 10.1161/hh0102.102795.
10
Pathogenic mechanisms mediating antiphospholipid syndrome.
Curr Opin Rheumatol. 2001 Sep;13(5):377-82. doi: 10.1097/00002281-200109000-00006.
Zotero 插件